These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19932062)

  • 1. Can Burkholderia cepacia complex be eradicated with nebulised amiloride and TOBI?
    Ball R; Brownlee KG; Duff AJ; Denton M; Conway SP; Lee TW
    J Cyst Fibros; 2010 Jan; 9(1):73-4. PubMed ID: 19932062
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination aerosol therapy to treat Burkholderia cepacia complex.
    Middleton PG; Kidd TJ; Williams B
    Eur Respir J; 2005 Aug; 26(2):305-8. PubMed ID: 16055880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of cepacia syndrome with combination nebulised and intravenous antibiotic therapy.
    Weidmann A; Webb AK; Dodd ME; Jones AM
    J Cyst Fibros; 2008 Sep; 7(5):409-11. PubMed ID: 18356119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
    Kitt H; Lenney W; Gilchrist FJ
    BMC Pharmacol Toxicol; 2016 Mar; 17():14. PubMed ID: 27018049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkholderia cepacia complex infection in adult patients with cystic fibrosis--is early eradication possible?
    Etherington C; Peckham DG; Conway SP; Denton M
    J Cyst Fibros; 2003 Dec; 2(4):220-1. PubMed ID: 15463878
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro interactions of tobramycin with various nonantibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia.
    Treerat P; Widmer F; Middleton PG; Iredell J; George AM
    FEMS Microbiol Lett; 2008 Aug; 285(1):40-50. PubMed ID: 18513356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
    Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled amiloride and tobramycin solutions fail to eradicate Burkholderia dolosa in patients with cystic fibrosis.
    Uluer AZ; Waltz DA; Kalish LA; Adams S; Gerard C; Ericson DA
    J Cyst Fibros; 2013 Jan; 12(1):54-9. PubMed ID: 23046902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of cepacia syndrome.
    Grimwood K; Kidd TJ; Tweed M
    J Cyst Fibros; 2009 Jul; 8(4):291-3. PubMed ID: 19411195
    [No Abstract]   [Full Text] [Related]  

  • 10. Pilot trial of tobramycin inhalation powder in cystic fibrosis patients with chronic Burkholderia cepacia complex infection.
    Waters V; Yau Y; Beaudoin T; Wettlaufer J; Tom SK; McDonald N; Rizvi L; Klingel M; Ratjen F; Tullis E
    J Cyst Fibros; 2017 Jul; 16(4):492-495. PubMed ID: 28262569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience.
    De Soyza A; Meachery G; Hester KL; Nicholson A; Parry G; Tocewicz K; Pillay T; Clark S; Lordan JL; Schueler S; Fisher AJ; Dark JH; Gould FK; Corris PA
    J Heart Lung Transplant; 2010 Dec; 29(12):1395-404. PubMed ID: 20810293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
    Moriarty TF; McElnay JC; Elborn JS; Tunney MM
    Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime plasma concentration in a patient with cystic fibrosis treated with ceftazidime/avibactam plus trimethoprim/sulfametoxazole for
    Saffioti C; Barco S; Cangemi G; Mesini A; Casciaro R; Cresta F; Castellani C; Bandettini R; Morelli P; Castagnola E
    J Chemother; 2019; 31(7-8):436-438. PubMed ID: 31583970
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients.
    Ratjen A; Yau Y; Wettlaufer J; Matukas L; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V
    Antimicrob Agents Chemother; 2015 Jan; 59(1):711-3. PubMed ID: 25348526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009.
    Lillquist YP; Cho E; Davidson AG
    J Cyst Fibros; 2011 May; 10(3):175-80. PubMed ID: 21310671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burkholderia cepacia complex and cystic fibrosis: in search of the smoking gun.
    Speert DP; Goldberg JB
    Am J Respir Crit Care Med; 2004 Jul; 170(1):6-7. PubMed ID: 15220120
    [No Abstract]   [Full Text] [Related]  

  • 17. Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients.
    Garcia BA; Carden JL; Goodwin DL; Smith TA; Gaggar A; Leon K; Antony VB; Rowe SM; Solomon GM
    BMC Pulm Med; 2018 Feb; 18(1):35. PubMed ID: 29444656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of breakpoint combination sensitivity testing as a simple and convenient method to evaluate the combined effects of ceftazidime and tobramycin on Pseudomonas aeruginosa and Burkholderia cepacia complex isolates in vitro.
    Tunney MM; Scott EM
    J Microbiol Methods; 2004 Apr; 57(1):107-14. PubMed ID: 15003693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolation and identification of Burkholderia cepacia complex from cystic fibrosis patients].
    Yurdakul P; Ergünay K; Yalçin E; Doğru D; Sener B; Cobanoğlu N; Ozçelik U; Kiper N
    Mikrobiyol Bul; 2006 Oct; 40(4):301-6. PubMed ID: 17205687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antibiotic combinations proposed for treatment of
    El-Halfawy OM; Naguib MM; Valvano MA
    Antimicrob Resist Infect Control; 2017; 6():120. PubMed ID: 29204272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.